Medicine Prices in Asia–Pacific Countries

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The chapter summarizes the studies that evaluated medicine prices in Asia–Pacific countries. The primary aim of this review was to report medicine prices in Asia–Pacific region in the last decade and document their significant findings. Almost all included studies have employed World Health Organization/Health Action International methodology to report medicine prices data. The included studies focused on the prices of cancer medicines, central nervous system–related disorders, hepatitis C, and essential medicines for chronic conditions. Affordability is particularly reviewed with medicine prices with a focus on generic medicines for cost savings. Finally, the challenges in formulating medicine pricing policy in Asia–Pacific region are discussed.
Original languageEnglish
Title of host publicationMedicine Price Surveys, Analyses and Comparisons
Subtitle of host publicationEvidence and Methodology Guidance
EditorsSabine Vogler
PublisherElsevier
Chapter2.3
Pages45-60
Number of pages16
Edition1st
ISBN (Electronic)9780128132128
ISBN (Print)9780128131664
DOIs
Publication statusPublished - 2019

Fingerprint Dive into the research topics of 'Medicine Prices in Asia–Pacific Countries'. Together they form a unique fingerprint.

Cite this